There’s a continued flight from inorganic to organic growth investment opportunities for primary care and urgent care models. Those companies with organic growth levers (e.g., service line enhancement/expansion) and/or a clear de novo growth strategy are seeing premium valuations over traditional buy-and-build models.
Key takeaways include:
- How healthcare platforms can stand out from their local and regional competitors
- Why equity investment and M&A activity are poised to accelerate in the primary care and urgent care industries
- What factors will drive consolidation in the Provider Services industry in 2025
BGL’s Healthcare Provider Services Group is one of the most experienced and respected financial advisory teams in the U.S. for physician practice M&A, with a long track record of expertise in successfully advising private equity firms, physicians, and alternate site providers through strategic transactions.
Please complete the form above to download your complimentary copy.